Latest Articles
Health chiefs target faster endometriosis diagnoses for women - Harrow Times
Health chiefs target faster endometriosis diagnoses for women Harrow Times
Published: Nov. 11, 2024, 2:10 p.m.
Health chiefs target faster endometriosis diagnoses for women - Halesowen News
Health chiefs target faster endometriosis diagnoses for women Halesowen News
Published: Nov. 11, 2024, 2:10 p.m.
Health chiefs target faster endometriosis diagnoses for women - The Independent
Health chiefs target faster endometriosis diagnoses for women The Independent
Published: Nov. 11, 2024, 1:59 p.m.
Health chiefs target faster endometriosis diagnoses for women - Kent Online
Health chiefs target faster endometriosis diagnoses for women Kent Online
Published: Nov. 11, 2024, 1:59 p.m.
Wisp Launches Weight Care Services Targeting Hormone-Related Weight Management - Femtech Insider
Wisp Launches Weight Care Services Targeting Hormone-Related Weight Management Femtech Insider
Published: Nov. 5, 2024, 10:42 a.m.
Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis - Nature.com
Apolipoprotein-B mRNA-editing complex 3B could be a new potential therapeutic target in endometriosis Nature.com
Published: Oct. 23, 2024, 4:55 a.m.
Having endometriosis can increase ovarian cancer risk 4.2-fold - TechTarget
Having endometriosis can increase ovarian cancer risk 4.2-fold TechTarget
Published: July 19, 2024, 7 a.m.
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer - Medpage Today
The Latest on Targeted Agents, Immunotherapy for Endometrial Cancer Medpage Today
Published: July 5, 2024, 7 a.m.
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More - Targeted Oncology
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Approvals, T-DXd Shows Promise in Breast Cancer, and More Targeted Oncology
Published: June 23, 2024, 7 a.m.
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology - Nature.com
Androgen-responsive FOXP4 is a target for endometrial carcinoma | Communications Biology Nature.com
Published: June 18, 2024, 7 a.m.
Link copied to clipboard!